0001214659-21-010561.txt : 20211018
0001214659-21-010561.hdr.sgml : 20211018
20211018170057
ACCESSION NUMBER: 0001214659-21-010561
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211015
FILED AS OF DATE: 20211018
DATE AS OF CHANGE: 20211018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McGrath Lynne Fahey
CENTRAL INDEX KEY: 0001866270
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40483
FILM NUMBER: 211328782
MAIL ADDRESS:
STREET 1: 28145 CEDAR POINT RD.
CITY: EASTON
STATE: MD
ZIP: 21601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alzamend Neuro, Inc.
CENTRAL INDEX KEY: 0001677077
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811822909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 3802 SPECTRUM BLVD,
STREET 2: SUITE C112C
CITY: TAMPA
STATE: FL
ZIP: 33612
BUSINESS PHONE: 844-722-6333
MAIL ADDRESS:
STREET 1: 3802 SPECTRUM BLVD,
STREET 2: SUITE C112C
CITY: TAMPA
STATE: FL
ZIP: 33612
4
1
marketforms-54024.xml
PRIMARY DOCUMENT
X0306
4
2021-10-15
0001677077
Alzamend Neuro, Inc.
ALZN
0001866270
McGrath Lynne Fahey
3802 SPECTRUM BOULEVARD, SUITE 112C
TAMPA
FL
33612
true
false
false
false
Common Stock
2021-10-15
4
M
false
47222
0
A
50000
D
Restricted Stock Grant
2021-10-15
4
M
false
47222
0
D
2022-03-15
Common Stock
47222
50000
D
Represents the vesting of restricted stock.
Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
The restricted stock grant was amended on October 13, 2021, such that 47,222 shares of restricted stock vested on October 15, 2021, and the remaining 50,000 shares of restricted stock shall vest on March 15, 2022. 2,778 shares previously vested on September 13, 2021.
/s/ Lynne F. McGrath
2021-10-18